跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CATHEJELL LIGNOCAINE GEL 2% W/W - HSA Drug Approval Details
Approvals
/
HSA
/
CATHEJELL LIGNOCAINE GEL 2% W/W
Approved
THERAPEUTIC
CATHEJELL LIGNOCAINE GEL 2% W/W
PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H. (AUSTRIA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 15, 2019
Approval ID
073b3740fbe8b5bc
Company
PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H. (AUSTRIA)
Type
Therapeutic
Approval Details
Approval Id
073b3740fbe8b5bc
Drug Name
CATHEJELL LIGNOCAINE GEL 2% W/W
Product Name
CATHEJELL LIGNOCAINE GEL 2% W/W
Approval Number
SIN15780P
Approval Date
2019-08-15
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
GEL, JELLY
Route Of Administration
TOPICAL
Atc Code
N01BB02
Atc Item Name
lidocaine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
LIGNOCAINE HYDROCHLORIDE MONOHYDRATE 2.33 g/100 g EQV LIGNOCAINE HYDROCHLORIDE
20 mg/g
LIGNOCAINE HYDROCHLORIDE MONOHYDRATE 2.33 G/100 G EQV LIGNOCAINE HYDROCHLORIDE
20 MG/G
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 15, 2019
Approval ID
073b3740fbe8b5bc
Type
Therapeutic
Back to HSA Approvals